Form 8-K Conatus Pharmaceuticals For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Conatus Pharmaceuticals (CNAT) Tops Q3 EPS by 7c
November 4, 2015 4:53 PM ESTConatus Pharmaceuticals (NASDAQ: CNAT) reported Q3 EPS of ($0.31), $0.07 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Conatus Pharmaceuticals (CNAT) click here.
... More


